Resistin causes G1 arrest in colon cancer cells through upregulation of SOCS3

The association of resistin with cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis

(2015) Evan D. Muse et al.   ATHEROSCLEROSIS

Decorin in Human Colon Cancer

(2015) Marie C. Nyman et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY

Adenylyl Cyclase-Associated Protein 1 Is a Receptor for Human Resistin and Mediates Inflammatory Actions of Human Monocytes

(2014) Sahmin Lee et al.   Cell Metabolism

ROR1, an embryonic protein with an emerging role in cancer biology

(2014) Nicholas Borcherding et al.   Protein & Cell

Serum resistin: A biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters

(2013) Maria Dalamaga et al.   CLINICAL BIOCHEMISTRY

Microenvironmental regulation of tumor progression and metastasis

(2013) Daniela F Quail et al.   NATURE MEDICINE

Serum Resistin, Cardiovascular Disease and All-Cause Mortality in Patients with Type 2 Diabetes

(2013) Claudia Menzaghi et al.   PLoS One

The Onco-Embryonic Antigen ROR1 Is Expressed by a Variety of Human Cancers

(2012) Suping Zhang et al.   AMERICAN JOURNAL OF PATHOLOGY

SOCS3 is an endogenous inhibitor of pathologic angiogenesis

(2012) A. Stahl et al.   BLOOD

The role of resistin in colorectal cancer

(2012) Elisa Danese et al.   CLINICA CHIMICA ACTA

Central Resistin Overexposure Induces Insulin Resistance Through Toll-Like Receptor 4

(2012) Yacir Benomar et al.   DIABETES

The biology and mechanism of action of suppressor of cytokine signaling 3

(2012) Jeffrey J. Babon et al.   GROWTH FACTORS

An Isoform of Decorin Is a Resistin Receptor on the Surface of Adipose Progenitor Cells

(2011) Alexes C. Daquinag et al.   Cell Stem Cell

Mouse Resistin Modulates Adipogenesis and Glucose Uptake in 3T3-L1 Preadipocytes Through the ROR1 Receptor

(2011) Beatriz Sánchez-Solana et al.   MOLECULAR ENDOCRINOLOGY

Relationship of resistin levels with endometrial cancer risk

(2011) M. HLAVNA et al.   NEOPLASMA

High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer

(2010) E L Wang et al.   BRITISH JOURNAL OF CANCER

Hyperthermia-associated carboplatin resistance: Differential role of p53, HSF1 and Hsp70 in hepatoma cells

(2010) Aanchal Sharma et al.   CANCER SCIENCE

Liver-specific suppressor of cytokine signaling-3 deletion in mice enhances hepatic insulin sensitivity and lipogenesis resulting in fatty liver and obesity1

(2010) Nirupa Sachithanandan et al.   HEPATOLOGY

Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways

(2010) S-H Lee et al.   ONCOGENE

ATF-2 regulates lipopolysaccharide-induced transcription in macrophage cells

(2009) Noriyuki Hirose et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Resistin competes with lipopolysaccharide for binding to toll-like receptor 4

(2009) Andrej Tarkowski et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation

(2009) G. Solinas et al.   JOURNAL OF LEUKOCYTE BIOLOGY

MACROPHAGES, MORE THAN JUST SCAVENGERS: THEIR ROLE IN BREAST DEVELOPMENT AND CANCER

(2008) David E. Gyorki et al.   ANZ JOURNAL OF SURGERY

SOCS3 as a tumor suppressor in breast cancer cells, and its regulation by PRL

(2008) Johanna L. Barclay et al.   INTERNATIONAL JOURNAL OF CANCER